These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 30959925

  • 1. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion.
    Yun JW, Bae YK, Cho SY, Koo H, Kim HJ, Nam DH, Kim SH, Chun S, Joo KM, Park WY.
    Int J Mol Sci; 2019 Apr 06; 20(7):. PubMed ID: 30959925
    [Abstract] [Full Text] [Related]

  • 2. The RUNX1/RUNX1T1 network: translating insights into therapeutic options.
    Swart LE, Heidenreich O.
    Exp Hematol; 2021 Feb 06; 94():1-10. PubMed ID: 33217477
    [Abstract] [Full Text] [Related]

  • 3. ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.
    Hartmann L, Dutta S, Opatz S, Vosberg S, Reiter K, Leubolt G, Metzeler KH, Herold T, Bamopoulos SA, Bräundl K, Zellmeier E, Ksienzyk B, Konstandin NP, Schneider S, Hopfner KP, Graf A, Krebs S, Blum H, Middeke JM, Stölzel F, Thiede C, Wolf S, Bohlander SK, Preiss C, Chen-Wichmann L, Wichmann C, Sauerland MC, Büchner T, Berdel WE, Wörmann BJ, Braess J, Hiddemann W, Spiekermann K, Greif PA.
    Nat Commun; 2016 Jun 02; 7():11733. PubMed ID: 27252013
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
    Qin YZ, Wang Y, Xu LP, Zhang XH, Chen H, Han W, Chen YH, Wang FR, Wang JZ, Chen Y, Mo XD, Zhao XS, Chang YJ, Liu KY, Huang XJ.
    J Hematol Oncol; 2017 Feb 06; 10(1):44. PubMed ID: 28166825
    [Abstract] [Full Text] [Related]

  • 6. High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome.
    Krauth MT, Eder C, Alpermann T, Bacher U, Nadarajah N, Kern W, Haferlach C, Haferlach T, Schnittger S.
    Leukemia; 2014 Jul 06; 28(7):1449-58. PubMed ID: 24402164
    [Abstract] [Full Text] [Related]

  • 7. Salmon-coloured granules in residual acute myeloid leukaemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1.
    Chen D, Chen W.
    Br J Haematol; 2021 May 06; 193(4):691. PubMed ID: 33386742
    [No Abstract] [Full Text] [Related]

  • 8. Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with RUNX1::RUNX1T1.
    Li XP, Dai Y, Zhang WN, Pan MM, Mao J, Zhao B, Jiang L, Gao Y.
    Int Immunopharmacol; 2023 Dec 06; 125(Pt B):111178. PubMed ID: 37951201
    [Abstract] [Full Text] [Related]

  • 9. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
    Duployez N, Nibourel O, Marceau-Renaut A, Willekens C, Helevaut N, Caillault A, Villenet C, Celli-Lebras K, Boissel N, Jourdan E, Dombret H, Figeac M, Preudhomme C, Renneville A.
    Am J Hematol; 2014 Jun 06; 89(6):610-5. PubMed ID: 24616160
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Decoding of exon splicing patterns in the human RUNX1-RUNX1T1 fusion gene.
    Grinev VV, Migas AA, Kirsanava AD, Mishkova OA, Siomava N, Ramanouskaya TV, Vaitsiankova AV, Ilyushonak IM, Nazarov PV, Vallar L, Aleinikova OV.
    Int J Biochem Cell Biol; 2015 Nov 06; 68():48-58. PubMed ID: 26320575
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.
    Steinauer N, Guo C, Huang C, Wong M, Tu Y, Freter CE, Zhang J.
    Blood Adv; 2019 May 14; 3(9):1379-1393. PubMed ID: 31040112
    [Abstract] [Full Text] [Related]

  • 15. Persistent altered fusion transcript splicing identifies RUNX1-RUNX1T1+ AML patients likely to relapse.
    Ommen HB, Ostergaard M, Yan M, Braendstrup K, Zhang DE, Hokland P.
    Eur J Haematol; 2010 Feb 01; 84(2):128-32. PubMed ID: 19891700
    [Abstract] [Full Text] [Related]

  • 16. Assessing the miRNA sponge potential of RUNX1T1 in t(8;21) acute myeloid leukemia.
    Junge A, Zandi R, Havgaard JH, Gorodkin J, Cowland JB.
    Gene; 2017 Jun 05; 615():35-40. PubMed ID: 28322996
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).
    Abe A, Yamamoto Y, Katsumi A, Okamoto A, Tokuda M, Inaguma Y, Yamamoto K, Yanada M, Kanie T, Tomita A, Akatsuka Y, Okamoto M, Kameyama T, Mayeda A, Emi N.
    Int J Hematol; 2018 Aug 05; 108(2):208-212. PubMed ID: 29264741
    [Abstract] [Full Text] [Related]

  • 19. The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1.
    Yonezawa T, Takahashi H, Shikata S, Liu X, Tamura M, Asada S, Fukushima T, Fukuyama T, Tanaka Y, Sawasaki T, Kitamura T, Goyama S.
    J Biol Chem; 2017 Jul 28; 292(30):12528-12541. PubMed ID: 28536267
    [Abstract] [Full Text] [Related]

  • 20. Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia.
    Hornung R, Jurinovic V, Batcha AMN, Bamopoulos SA, Rothenberg-Thurley M, Amler S, Sauerland MC, Berdel WE, Wörmann BJ, Bohlander SK, Braess J, Hiddemann W, Lehmann S, Mareschal S, Spiekermann K, Metzeler KH, Herold T, Boulesteix AL.
    Sci Rep; 2018 Jul 26; 8(1):11293. PubMed ID: 30050054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.